📊 Score Breakdown
Offering Ability
65
Cash Runway
85
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
65%
💰 Capital Raise
73%
• Low cash runway: 4 months remaining
• Active shelf registration ($2M, 27% of market cap)
🔄 Reverse Split
70%
• 50-day avg $0.79 below $1 exchange minimum
• Only 4 months cash — financial pressure
🔁 Convertible Conversion
40%
• Significant convertible debt: 17% potential dilution
• Elevated convertible risk (60/100)
💹 Market Data
Market Cap$8.31M
Shares Outstanding10.50M
Float10.20M
Cash$2.64M
Debt$415.1K
Short InterestN/A
🏛 Institutional Holdings
9.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest770.9K
Days to Cover1.6
% of Float7.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Jun 30, 2024
xbrl
XBRL WARRANT
Sep 30, 2022
EFFECT
EFFECT
Mar 04, 2026
S-1/A
SHELF
Feb 20, 2026
S-1
SHELF
Jan 22, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for YCBD
📊 YCBD FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 YCBD Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.